Reuters Pharma USA 2024
At Reuters Pharma USA, a who’s who of executives from major pharma companies will gather in Philadelphia to go in-depth on every part of the business, from marketing and market access to re
Beckley builds case for its psychedelic depression therapy
Beckley Psytech, just months away from a readout of a phase 2b trial of its psychedelic therapy for treatment-resistant depression (TRD), has built anticipation with new d
Blackstone bankrolls Moderna’s flu shot with $750m
Moderna’s efforts to develop a range of mRNA vaccines for influenza have been bolstered with funding of up to $750 million from investment firm Blackstone Life Sciences.
How cell and gene therapies are infusing blood centres with ...
As the cell and gene therapy industry grapples with infrastructure challenges, help is emerging from an unlikely source – blood donation centres.
Reuters Pharma USA 2024 - Day 2
Wednesday brings much more Cell and Gene Therapy content, but we’ll also dip into the Marketing and Commercial tracks, looking at real-world evidence, value-based care, and omnichannel mark
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
PM Society Digital Awards 2024 – Open for Entries
The PM Society Digital Awards 2024 have opened for entries!
Next Gen Peptide Formulation & Delivery Summit
Exciting developments in the world of peptides!
13th HPAPI: Process Development for Highly Potent Drugs
The rise in novel, more potent compounds, alongside EU Annex 1, are mounting pressure on biopharma, CDMOs and equipment providers to evolve their industrial hygiene, process engineering and
3rd In Vivo Cell Engineering & Gene Editing Summit
Achieve Safe & Targeted In Vivo Delivery of Payloads with Clarity in Regulations & Appropriate Models to Advance the Next Frontier of In Vivo Editing from Research to Clinic
Pre-Filled Syringes West Coast Conference
SAE Media Group’s 8th Annual Pre-Filled Syringes West Coast Conference will be back for 2024 in the West Coast to bring together device developers, biotech and big pharma.